| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33729874_HAS_TOPIC_C0003232> <https://research.tib.eu/covid-19/entity/33729874_HAS_TOPIC_C0003451> <https://research.tib.eu/covid-19/entity/33729874_HAS_TOPIC_C0013059> <https://research.tib.eu/covid-19/entity/33729874_HAS_TOPIC_C0013218> <https://research.tib.eu/covid-19/entity/33729874_HAS_TOPIC_C0020336> <https://research.tib.eu/covid-19/entity/33729874_HAS_TOPIC_C0052796> <https://research.tib.eu/covid-19/entity/33729874_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33729874_HAS_TOPIC_C0279516> <https://research.tib.eu/covid-19/entity/33729874_HAS_TOPIC_C0360390> <https://research.tib.eu/covid-19/entity/33729874_HAS_TOPIC_C0596007> <https://research.tib.eu/covid-19/entity/33729874_HAS_TOPIC_C0678143> <https://research.tib.eu/covid-19/entity/33729874_HAS_TOPIC_C0687133> <https://research.tib.eu/covid-19/entity/33729874_HAS_TOPIC_C0699177> <https://research.tib.eu/covid-19/entity/33729874_HAS_TOPIC_C0729049> <https://research.tib.eu/covid-19/entity/33729874_HAS_TOPIC_C0795582> <https://research.tib.eu/covid-19/entity/33729874_HAS_TOPIC_C0886592> <https://research.tib.eu/covid-19/entity/33729874_HAS_TOPIC_C0949528> <https://research.tib.eu/covid-19/entity/33729874_HAS_TOPIC_C1257813> <https://research.tib.eu/covid-19/entity/33729874_HAS_TOPIC_C1257814> <https://research.tib.eu/covid-19/entity/33729874_HAS_TOPIC_C1257815> <https://research.tib.eu/covid-19/entity/33729874_HAS_TOPIC_C1257816> <https://research.tib.eu/covid-19/entity/33729874_HAS_TOPIC_C1258056> <https://research.tib.eu/covid-19/entity/33729874_HAS_TOPIC_C2717829> <https://research.tib.eu/covid-19/entity/33729874_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33729874_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/33729874_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Service de Pharmacie, Hôpital de la Timone, APHM, Marseille, France.\', \'Aix Marseille Univ, INSERM, INRAE, C2VN, Marseille, France.\', \'IHU-Méditerranée Infection, Marseille, France.\', \'Aix Marseille Univ, IRD, APHM, MEPHI, Marseille, France.\', \'Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France.\', \'Service de Cardiologie, Hôpital de la Timone, APHM, Marseille, France.\', \'Aix Marseille Univ, Laboratoire de Pharmacie Clinique, Marseille, France.\', \'Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Brouqui_Philippe> <https://research.tib.eu/covid-19/entity/Deharo_Jean-Claude> <https://research.tib.eu/covid-19/entity/Gautret_Philippe> <https://research.tib.eu/covid-19/entity/Hache_Guillaume> <https://research.tib.eu/covid-19/entity/Honor%C3%A9_St%C3%A9phane> <https://research.tib.eu/covid-19/entity/Raoult_Didier> <https://research.tib.eu/covid-19/entity/Rolain_Jean_Marc>
?:doi	10.1089/mdr.2020.0232
?:doi	<https://research.tib.eu/covid-19/entity/10.1089/mdr.2020.0232>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Review>
?:journal	Microbial drug resistance (Larchmont, N.Y.)
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33729874>
?:pmid	<https://research.tib.eu/covid-19/entity/33729874>
?:pmid	33729874
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
?:title	Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Property

Value

is ?:annotates of

?:authorAffiliation

[\'Service de Pharmacie, Hôpital de la Timone, APHM, Marseille, France.\', \'Aix Marseille Univ, INSERM, INRAE, C2VN, Marseille, France.\', \'IHU-Méditerranée Infection, Marseille, France.\', \'Aix Marseille Univ, IRD, APHM, MEPHI, Marseille, France.\', \'Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France.\', \'Service de Cardiologie, Hôpital de la Timone, APHM, Marseille, France.\', \'Aix Marseille Univ, Laboratoire de Pharmacie Clinique, Marseille, France.\', \'Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France.\']

?:citedBy

-1

?:creator

?:doi

10.1089/mdr.2020.0232

?:doi

<https://research.tib.eu/covid-19/entity/10.1089/mdr.2020.0232>

?:hasPublicationType

?:journal

Microbial drug resistance (Larchmont, N.Y.)

is ?:pmid of

<https://research.tib.eu/covid-19/entity/33729874>

?:pmid

<https://research.tib.eu/covid-19/entity/33729874>

?:pmid

33729874

?:publication_isRelatedTo_Disease

<https://research.tib.eu/covid-19/entity/Covid-19>

?:rankingScore_SJR

-1.0

?:rankingScore_hIndex

-1

?:title

Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity.

?:type

?:year

2021

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33729874>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33729874>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

Metadata